Henry Shelford, CEO and Co-Founder of ADHD UK, was quoted in the article and provided background information.
The article reports that GP practices in England are increasingly tightening or ending so-called “shared care” arrangements for people with ADHD, particularly when patients have been diagnosed privately. Under shared care, a GP agrees to continue prescribing and monitoring medication after initial specialist treatment — but many practices, citing workload and clinical responsibility concerns, are withdrawing support. This leaves patients without NHS prescriptions and often facing high private costs or long waits to re-enter NHS pathways.
Henry Shelford, CEO of ADHD UK, criticised this trend, warning that the loss of shared care is dangerous for patients and reflects deep-seated failures in how ADHD services are managed. He said it is “hateful and cruel how badly the overall NHS treats people with ADHD” and highlighted long waits for diagnosis alongside the withdrawal of shared-care support.
You can read the full article here: https://sendsationalfutures.com/news/crackdown-on-shared-care-arrangement-for-adhd-patients/
